Regeneron antibody drug reduces death in some Covid patients

CNBC’s Meg Tirrell joins ‘The News with Shepard Smith’ to discuss the Regeneron antibody drug, which reduces the risk of death by 20% in some Covid patients. The drug is a combination of two antibodies which combat the virus,
Wed, Jun 16 20217:18 PM EDT